Clinomics Enters Anti-Aging Business... 'From Genome Analysis to Aging Prevention'

[Asia Economy Reporter Hyungsoo Park] Clinomics, a genome-specialized company, is embarking on research, product development, and sales in the anti-aging field as part of its long-term business development.

On the 8th, it announced that it has formalized its entry into the Korean traditional medicine sector and signed a strategic Memorandum of Understanding (MOU) with the Korean Pain Thread Embedding Therapy Society regarding the "National Health Promotion and Anti-Aging Business."

Through this agreement, the Pain Thread Embedding Therapy Society will apply genetic cause analysis to pain and aging-related issues addressed in Korean traditional medicine. As a result, it plans to more accurately diagnose causes, derive treatment methods and personalized treatment procedure manuals, and develop customized treatment products for pain and aging.

Clinomics will identify each patient's genetic characteristics and, in relation to the anti-aging business, will first collaborate with the Korean Pain Thread Embedding Therapy Society to conduct market research and content development for the creation and supply of screening services. It plans to promote and market these services to pioneer the market.

Clinomics recently established the vision of "From Genome to Aging." Utilizing the vast supercomputer of the Ulsan Genome Regulatory Free Zone and the Ulsan 10,000 Genome Information, it has decided to pursue future product development for ultra-precise disease diagnosis, aging prediction, diagnosis, and treatment. The goal is practical application and product launch in 2024, pioneering personalized diagnostic fields encompassing both Western and Korean traditional medicine.

The strategy is to actively utilize genome big data to develop practical products in the traditional Korean medicine field in collaboration with related academic societies, hospitals, and companies. Based on individual genetic risks derived from DNA genetic testing, it will promote the omics transformation of Korean traditional medicine through a Korean medicine approach. Based on this, it plans to support higher-level precise diagnosis and treatment in the relevant fields.

This content was produced with the assistance of AI translation services.